Excerpts from DBS report

Analyst: Derek TAN & Geraldine WONG

Rebound is underway
• Anticipate FHT to ride the impending recovery in the travel sector in 2021 post vaccine distribution

Frasers Hospitality 

Share price: 
$0.475

Target: 
$0.70

• Portfolio anchored in key markets of Australia, UK and Singapore with potential for gradual border re-opening.

• Earnings rebased to assume a 4-year normalisation period but growth is in excess of 20% CAGR

• BUY maintained, TP raised to S$0.70 on lower WACC assumption

Investment Thesis

Compelling value. We maintain our view that Frasers Hospitality Trust (FHT) offers compelling value at 0.7x P/NAV, which is below replacement costs.

The current price which is 40% below pre-COVID level remains an attractive level for investors for an overlooked stock.

Prospective FY22F yields of c.8.0% is attractive.

Intercontinental Hotel SingaporeIntercontinental Hotel Singapore (406 rooms) is one of the 15 hotels in 6 countries under the Frasers Hospitality Trust. Photo: Company
A laggard no longer. We see FHT price catching up with peers, supported by a robust c.30% CAGR in DPUs over the medium term.

Its portfolio of Australia and European hotels (50% portfolio exposure) should start to see better prospects on the back of loosening of domestic travel restrictions while Singapore (36% exposure) sees incrementally stronger earnings come 2H21.

Our earnings cut is to reflect our latest updated sector growth profile.

A privatisation candidate? Given the Sponsor’s significant 62% stake in FHT and relative illiquidity vs peers, we believe that the stock remains an attractive take-over target given that it cost less than S$500m to take it private and gain control of FHT's portfolio of c.4000 room keys and landmark Singapore hotels.

Valuation: Our DCF-based TP is raised to S$0.70 as we assume lower WACC assumption as the sector heads towards an early cyclical recovery phase despite a cut in earnings.

Where we differ: We are generally higher than consensus on expectations that FHT can drive RevPAR on the back of a rebound in operating metrics.

Key Risks to Our View: Slower recovery in FY21 as COVID-19 remain protracted.


Full report here. 

You may also be interested in:


You have no rights to post comments

Counter NameLastChange
AEM Holdings3.330-0.050
Avi-Tech Electronics0.270-
Best World1.690-0.020
Broadway Ind0.075-
China Sunsine0.400-
ComfortDelGro1.2900.010
Delfi Limited1.230-0.040
Food Empire1.1100.010
Fortress Minerals0.325-
Geo Energy Res0.285-0.005
GSS Energy0.033-
Hong Leong Finance2.460-0.020
Hongkong Land (USD)3.4700.020
InnoTek0.410-
ISDN Holdings0.350-0.010
ISOTeam0.041-0.001
IX Biopharma0.048-
Jiutian Chemical0.031-
KSH Holdings0.315-
Leader Env0.068-0.002
Medtecs Intl0.138-0.002
Nordic Group0.400-
Oxley Holdings0.105-0.001
REX International0.183-0.006
Riverstone0.600-
Sinostar PEC0.137-
Southern Alliance Mining0.650-0.025
Straco Corp.0.445-
Sunpower Group0.295-
The Trendlines0.092-0.002
Totm Technologies0.048-
Uni-Asia Group0.940-
Wilmar Intl3.600-0.070
Yangzijiang Shipbldg1.590-0.030
 

We have 819 guests and no members online

rss_2 NextInsight - Latest News